Cross, Alan S <br/><br/>
Phase I study of detoxified Escherichia coli J5 lipopolysaccharide (J5dLPS)/group B meningococcal outer membrane protein (OMP) complex vaccine in human subjects.  [electronic resource] 

 -  Vaccine  Nov 2003 
 - 4576-87 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0264-410X 
<br/><br/><label>Standard No.: </label>10.1016/s0264-410x(03)00483-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Animals<br/>Antibodies, Bacterial--analysis<br/>Bacterial Outer Membrane Proteins--chemistry<br/>Colony Count, Microbial<br/>Cytokines--biosynthesis<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Humans<br/>Immune Sera--chemistry<br/>Immunization, Secondary<br/>Immunoglobulin A--biosynthesis<br/>Immunoglobulin G--biosynthesis<br/>Immunoglobulin M--biosynthesis<br/>Lipopolysaccharides--chemistry<br/>Male<br/>Meningococcal Infections--microbiology<br/>Meningococcal Vaccines--adverse effects<br/>Middle Aged<br/>Neisseria meningitidis--immunology<br/>Rabbits<br/>Rats<br/>Rats, Sprague-Dawley<br/>Vaccines, Conjugate--immunology